FNA - Gunggunge utang jangka dawa Paragon 28, Inc.

Tandha merek Paragon 28 Inc. (FNA)

This chart of stock quotes helps assess the effectiveness of Paragon 28, Inc. (FNA) management, which is successfully capturing the US market through the transparent development of robotics. The production base relies on modernized CNC machines operating near full capacity. Global growth and high profits are driven by patents and an extensive implant distribution network, with the indicator standing at 0.10.

FNA Paragon 28 Corp: Utang jangka dawa perusahaan ing interval 04.07.2022 - 26.04.2025
Produk mawa merek Paragon 28

The indicator is calculated by aggregating all credit obligations with a maturity exceeding twelve months. This metric determines the long-term financial stability and the firm's ability to service capital loans. For Paragon 28, Inc. (FNA), which focuses on R&D and production outsourcing, this debt volume is critical for maintaining operational independence from vendors. By analyzing the company's long-term debt status, an investor assesses deleveraging risks. The trajectory of this chart correlates directly with the company's free liquidity.

Karo sapa Paragon 28, Inc. saingan

BSX - Kewajiban jangka dawa perusahaan|Edwards Lifesciences Corporation - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa ResMed Inc RMD|PODD: Utang jangka dawa perusahaan|Zimmer Biomet Holdings, Inc. (ZBH) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan The Cooper Companies|Utang jangka dawa perusahaan ALGN|Utang jangka dawa perusahaan GMED|Gunggunge utang jangka dawa TransMedics Group|ATEC Spine - Kewajiban jangka dawa perusahaan|AORT (Artivion Corp) - Kewajiban jangka dawa|Enovis Corporation - Utang jangka dawa perusahaan|Utang jangka dawa integralife.com|ESTA: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan BBNX|Kewajiban jangka dawa perusahaan IRMD|EMBC: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Tandem Diabetes Care (TNDM)|Kewajiban jangka dawa perusahaan axogeninc.com AXGN|Utang jangka dawa perusahaan SIBN (SI-BONE)|Orthofix Medical (OFIX) - Utang jangka dawa|Bioventus Corp - Utang jangka dawa perusahaan|KIDS (OrthoPediatrics Corp.) - Tanggungan utang jangka dawa perusahaan|TMCI: Utang jangka dawa perusahaan|SRTA - Gunggunge utang jangka dawa|CARL (Carlsmed) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan RxSight Inc (RXST)|Utang jangka dawa perusahaan CLPT|Utang jangka dawa perusahaan Stereotaxis Corporation (STXS)|Utang jangka dawa perusahaan Neuronetics, Inc. STIM|sightsciences.com - Utang jangka dawa perusahaan|OBIO: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan ANIK (Anika Therapeutics)|NSPR: Utang jangka dawa perusahaan|Utang jangka dawa Jin Medical (ZJYL)|Utang jangka dawa perusahaan Vivani Medical Inc|XTNT - Tanggungan jangka dawa|Kewajiban jangka dawa perusahaan NMTC (NeuroOne Medical Technologies Corporation)|Utang jangka dawa perusahaan modular-medical.com (MODD)|Utang jangka dawa perusahaan MYO (Myomo, Inc)|Gunggunge utang jangka dawa Envoy Medical Inc (COCH)|VVOS - Utang jangka dawa perusahaan|Kewajiban jangka dawa NVNO|sintx.com (SINT) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Tenon Medical Inc.|LFWD (ReWalk Robotics Ltd) - Utang jangka dawa perusahaan|Utang jangka dawa Autonomix AMIX|Utang jangka dawa perusahaan INVO Fertility Inc (IVF)|bonebiologics.com - Tanggungan utang jangka dawa perusahaan|Axonics - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka dawa BIOL (BIOLASE Inc.)|DYNT - Utang jangka dawa perusahaan|Kewajiban jangka dawa INVO